Fredun Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002605, "name": "Fredun Pharma", "stock_name": "Fredun Pharma", "full_name": "Fredun Pharmaceuticals Ltd", "name_url": "stocks-analysis/fredun-pharma", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "2,495.40", "chg": -82.05, "chgp": "-3.18%", "dir": -1, "prev_price": "2,577.45", "mcapval": "1,396.00 Cr", "mcap": "Micro Cap", "scripcode": 539730, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE194R01017", "curr_date": "Jun 23, 03:30 PM", "curr_time": "06:04 AM", "last_traded_at": "Jun 23, 03:30 PM IST", "bse_nse_vol": "19.52 k", "exc_status": "Active", "traded_date": "Jun 23, 2026", "traded_date_str": "2026 06 23", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Fredun Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-4068860", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FredunPharmaceu_mojoScore_4068860.png", "date": "2026-06-23 10:11:18", "description": "Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 June 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Fredun Pharmaceuticals Gains 13.37%: 2 Key Milestones Drive Weekly Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-gains-1337-2-key-milestones-drive-weekly-surge-4065406", "imagepath": "", "date": "2026-06-20 13:03:34", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Jun:</strong> Stock opens at Rs.2,314.65 with modest gains</p>\n <p><strong>16 Jun:</strong> Sharp 9.42% jump to Rs.2,532.75 on increased volume</p>\n <p><strong>17 Jun:</strong> New 52-week high and all-time high reached near Rs.2,680</p>\n <p><strong>18 Jun:</strong> Continued gains with Rs.2,615.45 close</p>\n <p><strong>19 Jun:</strong> Week closes at Rs.2,619.70, up 0.16% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,310.75</div></div>\n <div ..." }, { "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2680", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2680-4059131", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FredunPharmaceu_priceRelatedfactors_4059131.png", "date": "2026-06-17 13:35:14", "description": "With a decisive surge to Rs 2680 on 17 Jun 2026, Fredun Pharmaceuticals Ltd has reached a new 52-week and all-time high, marking a remarkable rally from its low of Rs 791 just a year ago. This milestone caps a sustained period of strong price momentum, supported by a confluence of bullish technical indicators across multiple timeframes." }, { "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 2,649 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-all-time-high-marking-a-milestone-in-market-performance-4059118", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FredunPharmaceu_priceRelatedfactors_4059118.png", "date": "2026-06-17 13:12:41", "description": "" }, { "title": "Fredun Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-4048819", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FredunPharmaceu_mojoScore_4048819.png", "date": "2026-06-12 10:10:41", "description": "Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 June 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Fredun Pharmaceuticals Upgraded to Buy on Strong Financial and Valuation Metrics", "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-upgraded-to-buy-on-strong-financial-and-valuation-metrics-4025596", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FredunPharmaceu_mojoScore_4025596.png", "date": "2026-06-01 08:23:19", "description": "Fredun Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its financial performance, valuation metrics, quality indicators, and technical outlook. The micro-cap pharmaceutical company’s recent quarterly results, improved valuation multiples, and sustained operational momentum have collectively driven this positive revision in its investment grade." }, { "title": "Fredun Pharmaceuticals Ltd Declines 1.32% Despite Strong Financials and Valuation Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-declines-132-despite-strong-financials-and-valuation-shift-4022877", "imagepath": "", "date": "2026-05-30 13:03:11", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> New 52-week and all-time high reached at Rs.2,620</p>\n <p><strong>26 May:</strong> Strong quarterly results reported amid margin pressures</p>\n <p><strong>27 May:</strong> Valuation shift noted, enhancing price attractiveness</p>\n <p><strong>29 May:</strong> Stock rebounds with a 5.27% gain despite Sensex decline</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,528.85</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-va..." }, { "title": "Fredun Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-hold-4017898", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_mojoScore_4017898.png", "date": "2026-05-28 10:10:30", "description": "Fredun Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 May 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Fredun Pharmaceuticals Ltd: Valuation Shift Enhances Price Attractiveness Amid Robust Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-valuation-shift-enhances-price-attractiveness-amid-robust-returns-4015644", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_valuationdot_4015644.png", "date": "2026-05-27 08:01:41", "description": "Fredun Pharmaceuticals Ltd has undergone a notable shift in its valuation parameters, moving from an expensive to an attractive price range. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positions the micro-cap pharmaceutical company as a compelling consideration within its sector amid robust returns and improving fundamentals." } ], "total": 281, "sid": "1002605", "stock_news_url": "https://www.marketsmojo.com/news/fredun-pharmaceuticals-1002605" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "12-Jun-2026", "details": "Transcript of the Earnings conference call held on 10th June 2026 for Q4 FY26.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "10-Jun-2026", "details": "Audio Recording of the Q4 and year ended for the FY26 Earnings Conference Call", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "09-Jun-2026", "details": "Newspaper Clipping- Information regarding 39th Annual General Meeting to be held on 30th June 2026 through video conference/other audio visual means.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Jun 26", "dt": "2026-06-23", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: New 52-week and all-time high reached at Rs.2,620

26 May: Strong quarterly results reported amid margin pressures

27 May: Valuation shift noted, enhancing price attractiveness

29 May: Stock rebounds with a 5.27% gain despite Sensex decline

Week Open

Rs.2,528.85

Week Close

Read full news article

Fredun Pharmaceuticals Ltd is Rated Hold

2026-05-28 10:10:30

Fredun Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 May 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Fredun Pharmaceuticals Ltd: Valuation Shift Enhances Price Attractiveness Amid Robust Returns

2026-05-27 08:01:41

Fredun Pharmaceuticals Ltd has undergone a notable shift in its valuation parameters, moving from an expensive to an attractive price range. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positions the micro-cap pharmaceutical company as a compelling consideration within its sector amid robust returns and improving fundamentals.

Read full news article